LEASE by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership and UNITY BIOTECHNOLOGY, INC., a Delaware corporationLease • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
THIS LEASE (this “Lease”) is entered into as of this 13th day of May, 2016 (the “Execution Date”), by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (“Landlord”), and UNITY BIOTECHNOLOGY, INC., a Delaware corporation (“Tenant”).
UNITY BIOTECHNOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Tamara Tompkins (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of May 31, 2017 (“Offer Letter”).
UNITY BIOTECHNOLOGY, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Keith R. Leonard, Jr. (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain Employment Agreement by and between Executive and the Company dated as of October 26, 2016 (the “Prior Agreement”).
COMPOUND LIBRARY AND OPTION AGREEMENTCompound Library and Option Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
This Compound Library and Option Agreement (the “Agreement”), dated as of February 2nd, 2016 (the “Signing Date”), is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 1700 Owens Street, Suite 535, San Francisco, California 95158. Ascentage and Unity are sometimes referred to herein as individually as a party and collectively as the parties.
SECOND AMENDMENT TO SPACE LICENSE AGREEMENTSpace License Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS SECOND AMENDMENT TO SPACE LICENSE AGREEMENT (this “Amendment”) is entered into as of this 30th day of January, 2017 (the “Second Amendment Execution Date”), by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (“Owner”), and UNITY BIOTECHNOLOGY, INC., a Delaware corporation (“User”).
APG1252 License AgreementLicense Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
This APG1252 License Agreement (the “Agreement”) effective as of the 2nd day of Feburary, 2016, (the “Signing Date”) is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 1700 Owens Street, Suite 535, San Francisco, California 95158. Each of Ascentage and Unity shall be a “Party,” and both the “Parties.”
FIRST AMENDMENT TO SPACE LICENSE AGREEMENTSpace License Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO SPACE LICENSE AGREEMENT (this “Amendment”) is entered into as of this 5th day of December, 2016 (the “First Amendment Execution Date”), by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (“Owner”), and UNITY BIOTECHNOLOGY, INC., a Delaware corporation (“User”).
FIRST AMENDMENT TO APG1252 LICENSE AGREEMENTApg1252 License Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations
This Amendment (the “Amendment”), dated as of March 28, 2018 (the Amendment Effective Date”) is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 3280 Bayshore Blvd, Suite 100, Brisbane, California 95002. Ascentage and Unity are sometimes referred to herein as individually as a “Party” and collectively as the “Parties”.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
This Research Services Agreement (the “Agreement”) is made this 2nd day of February, 2016 (the “Signing Date”) by and between Ascentage Pharma Group Corp. Ltd., a [Hong Kong corporation] (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 1700 Owens Street, Suite 535, San Francisco, California 95158.
FIRST AMENDMENT TO LEASELease • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO LEASE (this “Amendment”) is entered into as of this 23rd day of May, 2017 (the “First Amendment Execution Date”), by and between BMR-BAYSHORE BOULEVARD LP, a Delaware limited partnership (“Landlord”), and UNITY BIOTECHNOLOGY, INC., a Delaware corporation (“Tenant”).
FIRST AMENDMENT TO COMPOUND LIBRARY AND OPTION AGREEMENTCompound Library and Option Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations
This Amendment (the “Amendment”), dated as of March 28, 2018 (the Amendment Effective Date”) is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 3280 Bayshore Blvd, Suite 100, Brisbane, California 95002. Ascentage and Unity are sometimes referred to herein as individually as a “Party” and collectively as the “Parties”.
